naturalX Health Ventures is a €100 million investment fund backed by Schwabe Group, a self-described global leader in plant-based pharmaceuticals. The fund invests in innovative, young companies in the field of consumer health.

naturalX Health Ventures

naturalX Health Ventures is the €100mio VC arm of Schwabe Group for its investments in innovative, young companies as well as relevant VC funds.
We are flexible and can invest from seed to late stage. Our focus lies on Series A and Series B investments, where strong signs of product-market fit can be shown. 
We invest into consumer healthcare and are particularly excited about mental health as well as proactive health, including sleep, nootropics, nutrition, prevention & longevity, bio-hacking, consumer diagnostics and more. We do not invest into biotech or medtech at this stage.
Schwabe Group, our parent company, is a global leader in plant-based pharmaceuticals with about €950 million in revenue mainly across Europe and North America.
The aim of investing is to combine the growth potential of young, innovative companies with the financial strength and access to different expertise of our parent company. We are a strategic-financial investor.

We have been under the radar and plan to slowly change this. Yesterday, we hosted our first event together with Calm/Storm in Amsterdam as part of the HLTH Europe.

Hey there, HealthTech enthusiasts! 👋

Will you be in #Amsterdam next week for HLTH Europe? 

Join us for breakfast with our friends at naturalX Health Ventures! 🥐☕ Whether you’re a VC, founder, or industry veteran, we hope to see you there. We still have a few spaces left, so it’s not too late to register.

📅 Date: 18th June
⏰ Time: 8:45am-11am
📍 Location: The Hoxton, Amsterdam

Register here 👉 https://lnkd.in/dAh7jfFF and reach out to Johannes Blaschke, Carina Roth, Lucanus ⛵️ Polagnoli, or Ekaterina Gianelli to connect at the conference!

cc: Amazon Web Services (AWS) Guy Spigelman ABA - INVEST in AUSTRIA Gerlinde Gahleitner Verena Gruber Marion Biber

#HLTHAmsterdam #HealthTech #Networking #BreakfastEvent #Innovation #CalmStorm #naturalXHealthVentures

We are co-hosting a Networking Breakfast on June 18th at HLTH Europe together with our from Calm/Storm. Register here to secure one of the spots ➡️ https://lnkd.in/dy2FmFXX

I was honored to participate in the inaugural Lakestar Healthcare Symposium last week, alongside 50 esteemed entrepreneurs, regulators, and investors from the healthcare industry, including former Minsters of Health Jens Spahn, Dr. Philipp Rösler, and Daniel Bahr. Many thanks to Oliver Heimes for the invitation.

Held at the Berlin Museum of Medical History at the Charité in Berlin, the symposium provided sharp and thought-provoking insights about the German political landscape and the state of digitisation in healthcare.

One key takeaway for me was the perspective of insurers on prevention. While many envision a transition from sick care to healthcare, the reallocating funds from disease treatment to prevention (and longevity), insurers remain skeptical on this topic.

For insurers, the financial equation must make sense. Does a customer truly cost less if they engage in preventative care? Or does an increase in lifespan result in higher costs? Perhaps, ironically, the most profitable scenario is a customer who lives unhealthily and passes away prematurely...

For the April edition of Longevity Wednesdays, we brought together a stellar lineup of scientists, entrepreneurs, and investors in the longevity space for an invite-only dinner just outside Lisbon, sponsored by naturalX Health Ventures.

With the vision of fostering a vibrant community in Lisbon, Nina Patrick, PhD, Michele Gallia, and I launched Longevity Wednesdays last year. Our aim? To connect like-minded professionals passionate about advancing the field of longevity. Stay tuned for more exciting events to come! #Longevity #Lisbon 

Thank you everyone for coming! 

Pedro de Noronha Pissarra
Adrienne Alyzee
Pedro "Henrich" Azevedo
Maria Corlianò, Ph.D.
Joël Palix
Yang C.
Jeffrey Krone
Clara Burtenshaw
Tamsin Chislett
Dr. Sabine Krofczik-Wilhelm
Sebastian Rinnebach

Metric
Company Name	naturalX Health Ventures
Symbol
MSH ID	VC:NATURALX
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital
Country	DE
Stage
Employee Count
Website	naturalx.vc
LinkedIn	naturalx-health-ventures
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

NATU

VC:NATURALX

naturalX Health Ventures

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue